Huang, Y., Ling, X., Yuan, R., Chen, Z., Yang, S., Huang, H., . . . Qiu, S. (2017). miR-30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein. Mol Med Rep.
Citación estilo ChicagoHuang, Ya-Qiang, Xiao-Hui Ling, Run-Qiang Yuan, Zhi-Yun Chen, Sheng-Bang Yang, Hong-Xing Huang, Wei-De Zhong, y Shao-Peng Qiu. "MiR-30c Suppresses Prostate Cancer Survival By Targeting the ASF/SF2 Splicing Factor Oncoprotein." Mol Med Rep 2017.
Cita MLAHuang, Ya-Qiang, et al. "MiR-30c Suppresses Prostate Cancer Survival By Targeting the ASF/SF2 Splicing Factor Oncoprotein." Mol Med Rep 2017.
Precaución: Estas citas no son 100% exactas.